HRS9531 injection / Jiangsu Hengrui Pharma  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
HRS9531 injection / Jiangsu Hengrui Pharma
NCT06396429: To Compare the Efficacy and Safety of HRS9531 and Placebo in Subjects With Overweight or Obese

Recruiting
3
540
RoW
HRS9531 injection, Placebo
Fujian Shengdi Pharmaceutical Co., Ltd.
Overweight or Obesity
07/25
08/25

Download Options